2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with oxidopamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, G; Chen, J; Ding, Y; Liang, Q; Liou, AK; Perez, RG; Xiao, X | 1 |
1 other study(ies) available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and oxidopamine
| Article | Year |
|---|---|
6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression.
Topics: Animals; Animals, Newborn; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Survival; Cells, Cultured; Cysteine Proteinase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Fluorescent Antibody Technique; gamma-Aminobutyric Acid; Gene Expression Regulation; L-Lactate Dehydrogenase; Mutation; Nerve Degeneration; Oligopeptides; Oxidopamine; Rats; Tetrazolium Salts; Time Factors; Transfection; Tyrosine 3-Monooxygenase | 2004 |